$TLYS
TILLY'S, INC. Stock $tlys

$tlys Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000162828022016650 Filed on June 09, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q2
Revenue	$145.8M	$204.5M	$163.2M
YoY Change	-10.65%	14.93%	111.1%
Cost Of Revenue	$102.0M	$134.1M	$108.3M
YoY Change	-5.87%	12.06%	43.1%
Gross Profit	$43.82M	$70.36M	$54.84M
YoY Change	-20.1%	20.76%	3340.34%
Gross Profit Margin	30.06%	34.41%	33.61%
Selling, General & Admin	$42.71M	$53.06M	$39.97M
YoY Change	6.86%	20.32%	33.24%
% of Gross Profit	97.47%	75.42%	72.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.508M	$3.713M	$4.324M
YoY Change	-18.87%	-17.31%	-13.86%
% of Gross Profit	8.01%	5.28%	7.88%
Operating Expenses	$42.71M	$53.06M	$39.97M
YoY Change	6.86%	20.32%	33.24%
Operating Profit	$1.108M	$17.30M	$14.87M
YoY Change	-92.55%	22.55%	-152.37%
Interest Expense	$25.00K	$9.000K	$29.00K
YoY Change	-13.79%		-90.33%
% of Operating Profit	2.26%	0.05%	0.19%
Other Income/Expense, Net	$4.000K	-$384.0K	-$115.0K
YoY Change	-103.48%	284.0%	-128.12%
Pretax Income	$1.112M	$16.92M	$14.76M
YoY Change	-92.47%	20.87%	-152.73%
Income Tax	$299.0K	$4.864M	$3.800M
% Of Pretax Income	26.89%	28.74%	25.75%
Net Earnings	$813.0K	$12.06M	$10.96M
YoY Change	-92.58%	35.93%	-163.0%
Net Earnings / Revenue	0.56%	5.9%	6.72%
Basic Earnings Per Share
Diluted Earnings Per Share	$26.19K	$383.7K	$359.0K
COMMON SHARES
Basic Shares Outstanding	30.76M shares		29.88M shares
Diluted Shares Outstanding	31.05M shares		30.53M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$111.0M	$139.2M	$157.6M
YoY Change	-29.61%	-1.34%	42.2%
Cash & Equivalents	$59.95M	$42.20M	$81.02M
Short-Term Investments	$51.00M	$97.03M	$76.60M
Other Short-Term Assets	$14.77M	$757.0K	$4.591M
YoY Change	221.69%	-5.96%	118.62%
Inventory	$74.11M	$65.65M	$65.34M
Prepaid Expenses
Receivables	$8.209M	$6.705M	$9.701M
Other Receivables	$0.00	$1.333M	$0.00
Total Short-Term Assets	$208.0M	$228.0M	$237.3M
YoY Change	-12.32%	7.67%	22.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.61M	$47.53M	$54.14M
YoY Change	-13.91%	-9.71%	-12.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.253M	$1.361M	$1.231M
YoY Change	1.79%	6.91%	-83.41%
Total Long-Term Assets	$277.6M	$276.8M	$289.2M
YoY Change	-4.02%	-6.38%	-10.15%
TOTAL ASSETS
Total Short-Term Assets	$208.0M	$228.0M	$237.3M
Total Long-Term Assets	$277.6M	$276.8M	$289.2M
Total Assets	$485.7M	$504.8M	$526.5M
YoY Change	-7.76%	-0.52%	2.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.19M	$28.14M	$35.86M
YoY Change	-24.17%	12.65%	44.38%
Accrued Expenses	$16.74M	$19.07M	$29.11M
YoY Change	-42.49%	-37.84%	114.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$122.2M	$136.2M	$146.8M
YoY Change	-16.75%	1.47%	2.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$872.0K	$978.0K	$1.528M
YoY Change	-42.93%	-27.61%	173.84%
Total Long-Term Liabilities	$195.5M	$193.9M	$205.2M
YoY Change	-4.69%	-8.79%	36666.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$122.2M	$136.2M	$146.8M
Total Long-Term Liabilities	$195.5M	$193.9M	$205.2M
Total Liabilities	$317.7M	$330.1M	$351.9M
YoY Change	-9.72%	-4.82%	-5.7%
SHAREHOLDERS EQUITY
Retained Earnings	$391.0K	$7.754M	$16.09M
YoY Change	-97.57%	51.0%	-244.8%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$167.9M	$174.7M	$174.6M
YoY Change
Total Liabilities & Shareholders Equity	$485.7M	$504.8M	$526.5M
YoY Change	-7.76%	-0.52%	2.0%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q2
OPERATING ACTIVITIES
Net Income	$813.0K	$12.06M	$10.96M
YoY Change	-92.58%	35.93%	-163.0%
Depreciation, Depletion And Amortization	$3.508M	$3.713M	$4.324M
YoY Change	-18.87%	-17.31%	-13.86%
Cash From Operating Activities	-$17.55M	$16.55M	$19.28M
YoY Change	-191.06%	-7.38%	-198.52%
INVESTING ACTIVITIES
Capital Expenditures	$2.598M	-$2.514M	$5.492M
YoY Change	-52.69%	21.45%	54.79%
Acquisitions
YoY Change
Other Investing Activities	$46.06M	-$753.0K	-$11.61M
YoY Change	-496.91%	-98.07%	-148.13%
Cash From Investing Activities	$43.46M	-$3.267M	-$17.10M
YoY Change	-354.21%	-92.04%	-183.14%
FINANCING ACTIVITIES
Cash Dividend Paid			$1.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net	$8.177M		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$8.157M	-30.48M	$2.651M
YoY Change	-407.7%	-101686.67%	-144.17%
NET CHANGE
Cash From Operating Activities	-$17.55M	16.55M	$19.28M
Cash From Investing Activities	$43.46M	-3.267M	-$17.10M
Cash From Financing Activities	-$8.157M	-30.48M	$2.651M
Net Change In Cash	$17.75M	-17.19M	$4.831M
YoY Change	267.48%	-25.64%	-196.54%
FREE CASH FLOW
Cash From Operating Activities	-$17.55M	$16.55M	$19.28M
Capital Expenditures	$2.598M	-$2.514M	$5.492M
Free Cash Flow	-$20.15M	$19.07M	$13.79M
YoY Change	-246.18%	-4.38%	-159.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Whatney
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2022Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92618
CY2022Q2	dei	City Area Code CityAreaCode	949
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	609-5599
CY2022Q2	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.001 par value per share
CY2022Q2	dei	Trading Symbol TradingSymbol	TLYS
CY2022Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001524025
CY2022Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-28
CY2022Q2	dei	Document Type DocumentType	10-Q
CY2022Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-04-30
CY2022Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	dei	Entity File Number EntityFileNumber	001-35535
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	TILLY’S, INC.
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2164791
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	174601000	USD
CY2022Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59954000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42201000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81015000	USD
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	50997000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	97027000	USD
CY2021Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	76633000	USD
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8209000	USD
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	6705000	USD
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9701000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	74112000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	65645000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	65341000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14769000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16400000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4591000	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	208041000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	227978000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	237281000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218163000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216508000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	222209000	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46606000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47530000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54139000	USD
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11594000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11446000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11664000	USD
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1253000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1361000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1231000	USD
CY2022Q2	us-gaap	Assets Assets	485657000	USD
CY2022Q1	us-gaap	Assets Assets	504823000	USD
CY2021Q2	us-gaap	Assets Assets	526524000	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	27193000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	28144000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	35860000	USD
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16741000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19073000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29110000	USD
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	15150000	USD
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17096000	USD
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12913000	USD
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8707000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17056000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14489000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	51237000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	51504000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	51231000	USD
CY2022Q2	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2483000	USD
CY2022Q1	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2533000	USD
CY2021Q2	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2402000	USD
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	674000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	761000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	763000	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	122185000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	136167000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	146768000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174301000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	171965000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	192345000	USD
CY2022Q2	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	20364000	USD
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	872000	USD
CY2022Q1	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	21000000	USD
CY2021Q2	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	11282000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	978000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1528000	USD
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	195537000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	193943000	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	205155000	USD
CY2022Q2	us-gaap	Liabilities Liabilities	317722000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	330110000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	351923000	USD
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4324000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167512000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	166929000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158454000	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	391000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7754000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16094000	USD
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	23000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	167935000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	174713000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	174601000	USD
CY2022Q2	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	0	USD
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	485657000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	504823000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	526524000	USD
CY2022Q2	us-gaap	Revenues Revenues	145775000	USD
CY2021Q2	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	117000	USD
CY2021Q2	us-gaap	Revenues Revenues	163157000	USD
CY2022Q2	tlys	Cost Of Goods And Services Sold Excluding Rent CostOfGoodsAndServicesSoldExcludingRent	101100000	USD
CY2021Q2	tlys	Cost Of Goods And Services Sold Excluding Rent CostOfGoodsAndServicesSoldExcludingRent	107616000	USD
CY2022Q2	tlys	Rent Expense Related Party Cost Of Goods Sold RentExpenseRelatedPartyCostOfGoodsSold	860000	USD
CY2021Q2	tlys	Rent Expense Related Party Cost Of Goods Sold RentExpenseRelatedPartyCostOfGoodsSold	702000	USD
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	101960000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	108318000	USD
CY2022Q2	us-gaap	Gross Profit GrossProfit	43815000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	54839000	USD
CY2022Q2	tlys	Selling General And Administrative Expenses Excluding Rent Expense SellingGeneralAndAdministrativeExpensesExcludingRentExpense	42574000	USD
CY2021Q2	tlys	Selling General And Administrative Expenses Excluding Rent Expense SellingGeneralAndAdministrativeExpensesExcludingRentExpense	39832000	USD
CY2022Q2	tlys	Rent Expense Related Party Selling General And Administrative Expenses RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses	133000	USD
CY2021Q2	tlys	Rent Expense Related Party Selling General And Administrative Expenses RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses	133000	USD
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42707000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39965000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1108000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	14874000	USD
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-115000	USD
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1112000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14759000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	299000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3800000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	10959000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30762000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29878000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31046000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30529000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	10959000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	816000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10962000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	174713000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	563000	USD
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000	USD
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8177000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	167935000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	160622000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	10959000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	366000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2651000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	10959000	USD
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3508000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10617000	USD
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	563000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	366000	USD
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	13000	USD
CY2021Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-62000	USD
CY2021Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-43000	USD
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	26000	USD
CY2021Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	29000	USD
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-150000	USD
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	285000	USD
CY2022Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	356000	USD
CY2021Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-250000	USD
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8467000	USD
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2357000	USD
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1745000	USD
CY2022Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8349000	USD
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9760000	USD
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1667000	USD
CY2021Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1615000	USD
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-955000	USD
CY2021Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4590000	USD
CY2022Q2	tlys	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-1361000	USD
CY2021Q2	tlys	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-2103000	USD
CY2022Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1946000	USD
CY2021Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-579000	USD
CY2022Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-193000	USD
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2100000	USD
CY2021Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2021Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	308000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17553000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19277000	USD
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2598000	USD
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	5900000	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5492000	USD
CY2022Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000	USD
CY2022Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2021Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	29000	USD
CY2022Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4967000	USD
CY2021Q1	us-gaap	Deferred Revenue DeferredRevenue	3900000	USD
CY2021Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	36644000	USD
CY2022Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	51028000	USD
CY2021Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	25000000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	43463000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17097000	USD
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000	USD
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2651000	USD
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8177000	USD
CY2021Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8157000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2651000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17753000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4831000	USD
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2100000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42201000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76184000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59954000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81015000	USD
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-58000	USD
CY2021Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3683000	USD
CY2022Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1108000	USD
CY2021Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2936000	USD
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14818	USD
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4621	USD
CY2022Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1900000	USD
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2200000	USD
CY2022Q2	tlys	Unredeemed Awardsand Accumulated Points Expiration Period UnredeemedAwardsandAccumulatedPointsExpirationPeriod	P365D
CY2022Q2	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	-500000	USD
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	5400000	USD
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	5900000	USD
CY2021Q2	us-gaap	Deferred Revenue DeferredRevenue	4500000	USD
CY2022Q2	us-gaap	Number Of Stores NumberOfStores	241	store
CY2022Q2	tlys	Number Of States NumberOfStates	33	State
CY2022Q2	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2022 refer to the fiscal year ending January 28, 2023. References to the fiscal quarters or first three months ended April 30, 2022 and May 1, 2021 refer to the thirteen week period ended as of those dates, respectively.</span></div>
CY2022Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2100000	USD
CY2022Q2	us-gaap	Revenues Revenues	145775000	USD
CY2021Q2	us-gaap	Revenues Revenues	163157000	USD
CY2022Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2021Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2022Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2022Q2	tlys	Lessee Operating Lease Lease Payment Adjustment Percentage LesseeOperatingLeaseLeasePaymentAdjustmentPercentage	0.05
CY2022Q2	tlys	Lessor Operating Lease Square Footage LessorOperatingLeaseSquareFootage	5887	sqft
CY2022Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P5Y
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	51784000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	65000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	59647000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	90000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	49260000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	95000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	40078000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	99000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	28814000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	104000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	64449000	USD
CY2022Q2	tlys	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	0	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	294032000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	453000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	45647000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	248385000	USD
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	3800000	USD
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	453000	USD
CY2022Q2	tlys	Lessor Operating Lease Not Yet Commenced Amount LessorOperatingLeaseNotYetCommencedAmount	10700000	USD
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	15596000	USD
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	15627000	USD
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	3888000	USD
CY2022Q2	us-gaap	Lease Cost LeaseCost	19397000	USD
CY2021Q2	us-gaap	Lease Cost LeaseCost	19515000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M6D
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	17166000	USD
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	17168000	USD
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0608
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0649
CY2022Q2	tlys	Income Tax Expense Benefit Narrative IncomeTaxExpenseBenefitNarrative	300000	USD
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.269
CY2021Q2	tlys	Income Tax Expense Benefit Narrative IncomeTaxExpenseBenefitNarrative	3800000	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.257
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11700000	USD
CY2021Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	400000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	50997000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19000	USD
CY2022Q2	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-19000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	50997000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	97029000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-11000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	97027000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	76602000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	32000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-1000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76633000	USD
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	13400	USD
CY2022Q2	tlys	Impaired Long Lived Assets Heldand Used Carrying Amount ImpairedLongLivedAssetsHeldandUsedCarryingAmount	13000	USD
CY2021Q2	tlys	Impaired Long Lived Assets Heldand Used Carrying Amount ImpairedLongLivedAssetsHeldandUsedCarryingAmount	0	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	USD
CY2022Q2	tlys	Impaired Long Lived Assets Heldand Used Fair Value ImpairedLongLivedAssetsHeldandUsedFairValue	0	USD
CY2021Q2	tlys	Impaired Long Lived Assets Heldand Used Fair Value ImpairedLongLivedAssetsHeldandUsedFairValue	0	USD
CY2022Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	2	store
CY2022Q2	tlys	Numberof Storeswith Impairment NumberofStoreswithImpairment	1	store
CY2021Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	9	store
CY2021Q2	tlys	Numberof Storeswith Impairment NumberofStoreswithImpairment	0	store
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1570211	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.02
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	502500	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.45
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4750	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.13
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.45
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2065961	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.14
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2231000	USD
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	815761	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.84
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	853000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	10959000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30762000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29878000	shares
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	651000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31046000	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y4M24D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.98
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.64
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.586
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.599
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.023
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30529000	shares
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	563000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	366000	USD
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5700000	USD
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	284000	shares
CY2022Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
CY2022Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	892033	shares
CY2022Q2	tlys	Stock Repurchase Program Weighted Average Price StockRepurchaseProgramWeightedAveragePrice	9.14
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8200000	USD
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	1107967	shares

Files In Submission

Name	View Source	Status
0001628280-22-016650-index-headers.html	Edgar Link	pending
0001628280-22-016650-index.html	Edgar Link	pending
0001628280-22-016650.txt	Edgar Link	pending
0001628280-22-016650-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q12022ex311.htm	Edgar Link	pending
q12022ex312.htm	Edgar Link	pending
q12022ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlys-20220430.htm	Edgar Link	pending
tlys-20220430.xsd	Edgar Link	pending
tlys-20220430_cal.xml	Edgar Link	unprocessable
tlys-20220430_def.xml	Edgar Link	unprocessable
tlys-20220430_htm.xml	Edgar Link	completed
tlys-20220430_lab.xml	Edgar Link	unprocessable
tlys-20220430_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLYS
TILLY'S, INC. Stock $tlys

2022 Q2 Form 10-Q Financial Statement

#000162828022016650 Filed on June 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS TILLY'S, INC. Stock $tlys

2022 Q2 Form 10-Q Financial Statement

#000162828022016650 Filed on June 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS
TILLY'S, INC. Stock $tlys